Akèy › Psoryaz › Texas › Dallas
Etid klinik pou Psoryaz nan Dallas, TX
3 etid pou Psoryaz ap chèche patisipan nan sit nan ak bò kote Dallas (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Ap rekriteFaz 1
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Ap rekriteFaz 4
- Modern Research Associates, PLLC, Dallas
Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis
Ap rekriteFaz 1
- Clinical Investigations of Texas, Dallas
Etid Psoryaz nan lòt vil
- Trenton, NJ7 etid
- Newton, MA6 etid
- Cleveland, OH6 etid
- Philadelphia, PA5 etid
- New York City, NY5 etid
- San Antonio, TX5 etid
- Fremont, CA5 etid
- Birmingham, AL4 etid
- Miami, FL4 etid
- Huntington Beach, CA4 etid
- Sacramento, CA3 etid
- Houston, TX3 etid
Lòt etid nan Dallas
- Kansè nan tete54 etid
- Kansè Poumon ki pa ti selil52 etid
- Ensifizyans kadyak42 etid
- Kansè Metastatik42 etid
- Kansè (tout kalite)38 etid
- Kansè pwostat36 etid
- Kansè kolorektal33 etid
- Obèsite31 etid
- Kansè ovè28 etid
- Kansè vejik27 etid
- Kansè poumon27 etid
- Kansè Endomèt25 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.